Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma
文献类型：期刊论文
| 作者 | Ma, SL; Liu, XS; Geng, JG; Guo, SW |
| 刊名 | AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
 |
| 出版日期 | 2010 |
| 卷号 | 202期号:1页码:680-680 |
| 关键词 | biomarker endometrial carcinoma recurrence ROBO1 SLIT |
| 通讯作者 | Guo, SW (reprint author), Shanghai Jiao Tong Univ, Sch Med, Inst Obstet & Gynecol Res, 145 Shandong Zhong Rd, Shanghai 200001, Peoples R China.,hoxa10@gmail.com |
| 英文摘要 | OBJECTIVE: We sought to investigate the potential predictive value of SLIT/ROBO1 immunoreactivity in recurrent and nonrecurrent endometrial cancer (EC), and the relationship between SLIT/Roundabout (ROBO1) immunoreactivity and microvessel density (MVD) in EC. STUDY DESIGN: From a total of 815 consecutive patients histologically diagnosed with EC who had undergone surgery we retrieved 45 patients who had confirmed recurrence and randomly selected 110 patients without recurrence. Their paraffin-embedded tissue blocks were also retrieved and subjected to immunohistochemistry for pan-SLIT and ROBO1. MVD counts were evaluated by CD34 immunohistochemistry. Univariate and multivariate analyses were performed to evaluate the effect of SLIT/ROBO1 on recurrence risk with adjustment for other known risk factors. RESULTS: Immunoreactivity to pan-SLIT and ROBO1 was higher in recurrence patients than that in nonrecurrence patients. Both SLIT and ROBO1 immunoreactivities were positively correlated with MVD. Cox regression analysis identified SLIT, along with age and International Federation of Gynecology and Obstetrics stage, as risk factors for recurrence. The resultant discrimination model yielded estimated and cross-validated sensitivity and specificity of 79% and 85%, respectively. CONCLUSION: Increased immunoreactivity to SLIT is an important factor for recurrence of EC, likely through attracting endothelial cells and promoting neovascularization. Thus, the SLIT immunoreactivity is likely a promising biomarker for recurrence and the SLIT/ROBO1 system may be a potential target for reducing the recurrence risk in EC. |
| 学科主题 | Obstetrics & Gynecology |
| 类目[WOS] | Obstetrics & Gynecology |
| 关键词[WOS] | GYNECOLOGIC-ONCOLOGY-GROUP ; FOLLOW-UP ; TUMOR ANGIOGENESIS ; CANCER ; STAGE ; EXPRESSION ; THERAPY ; MANAGEMENT ; GUIDANCE ; SURVIVAL |
| 收录类别 | SCI |
| 语种 | 英语 |
| WOS记录号 | WOS:000273026200019 |
| 版本 | 出版稿 |
| 源URL | [http://202.127.25.143/handle/331003/920]  |
| 专题 | 上海生化细胞研究所_上海生科院生化细胞研究所 |
| 推荐引用方式 GB/T 7714 | Ma, SL,Liu, XS,Geng, JG,et al. Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma[J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,2010,202(1):680-680. |
| APA | Ma, SL,Liu, XS,Geng, JG,&Guo, SW.(2010).Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma.AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY,202(1),680-680. |
| MLA | Ma, SL,et al."Increased SLIT immunoreactivity as a biomarker for recurrence in endometrial carcinoma".AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY 202.1(2010):680-680. |
入库方式： OAI收割
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。